We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our Privacy Policy.

Sleep Heart Health Study

Name Label Folder
ostrd1
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS1
tca1
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))

Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS1
ace2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
aced2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
benzod2
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
beta2
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
betad2
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
diur2
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
htnmed2
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
insuln2
Insulins (Sleep Heart Health Study Visit Two (SHHS2))
Insulins (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
istrd2
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking INHALED STEROIDS FOR ASTHMA within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
lipid2
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY LIPID-LOWERING MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
mlpd2
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking MISCELLANEOUS LIPID-LOWERING DRUGS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
oaia2
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
ohga2
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
ostrd2
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
tca2
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medical History/Medications/SHHS2
alcoh
Alcohol use (Sleep Heart Health Study Visit One (SHHS1))
Alcohol use (Sleep Heart Health Study Visit One (SHHS1))

Usual Alcohol Intake per day

Medical History/SHHS1
cgpkyr
Cigarette pack-years (Sleep Heart Health Study Visit One (SHHS1))
Cigarette pack-years (Sleep Heart Health Study Visit One (SHHS1))

Lifetime cigarette smoking: pack years

Medical History/SHHS1
parrptdiab
History of Diabetes (Sleep Heart Health Study Visit One (SHHS1))
History of Diabetes (Sleep Heart Health Study Visit One (SHHS1))

Parent Cohort reported Diabetes Status

Medical History/SHHS1
srhype
Self-reported hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))
Self-reported hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1)) Medical History/SHHS1
hi201a
History of Emphysema (Sleep Heart Health Study Visit Two (SHHS2))
History of Emphysema (Sleep Heart Health Study Visit Two (SHHS2))

1. Has a doctor ever told you that you have the following? a. Emphysema

Medical History/SHHS2
hi201b
History of Chronic Bronchitis (Sleep Heart Health Study Visit Two (SHHS2))
History of Chronic Bronchitis (Sleep Heart Health Study Visit Two (SHHS2))

1. Has a doctor ever told you that you have the following? b. Chronic bronchitis

Medical History/SHHS2
hi201c
History of chronic obstructive pulmonary disease (COPD) (Sleep Heart Health Study Visit Two (SHHS2))
History of chronic obstructive pulmonary disease (COPD) (Sleep Heart Health Study Visit Two (SHHS2))

1. Has a doctor ever told you that you have the following? c. chronic obstructive pulmonary disease (COPD)

Medical History/SHHS2
hi201d
History of Asthma (Sleep Heart Health Study Visit Two (SHHS2))
History of Asthma (Sleep Heart Health Study Visit Two (SHHS2))

1. Has a doctor ever told you that you have the following? d. Asthma

Medical History/SHHS2
hi201e
Current Asthma (Sleep Heart Health Study Visit Two (SHHS2))
Current Asthma (Sleep Heart Health Study Visit Two (SHHS2))

e. Do you still have asthma?

Medical History/SHHS2
hi216
History of restless leg syndrome (RLS) (Sleep Heart Health Study Visit Two (SHHS2))
History of restless leg syndrome (RLS) (Sleep Heart Health Study Visit Two (SHHS2))

16. Has a doctor ever told you that you have the following? restless leg syndrome (RLS)?

Medical History/SHHS2
htnderv_s1
Hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))
Hypertension (HTN) (Sleep Heart Health Study Visit One (SHHS1))

Hypertension (HTN) Status based on 2nd and 3rd blood pressure readings OR being treated with hypertension (HTN) meds

Medical History/SHHS2
htnderv_s2
Hypertension (HTN) (Sleep Heart Health Study Visit Two (SHHS2))
Hypertension (HTN) (Sleep Heart Health Study Visit Two (SHHS2))

Derived hypertension (HTN) classification (based on blood pressure measurements, history of hypertension (HTN) dx, and medication use)

Medical History/SHHS2
ahi_a0h3
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events.

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_a0h3a
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_a0h4
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.].

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_a0h4a
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: (Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_c0h3
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events.

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_c0h3a
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_c0h4
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.].

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_c0h4a
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Central Apnea-Hypopnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events.

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_o0h3
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events.

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_o0h3a
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 3% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition for hypopneas is consistent with the following clinical guidelines: (1) American Academy of Sleep Medicine (AASM) 2007 Manual (2012 update) (recommended). Berry RB et al. 2012 (PubMed ID:23066376), and (2) American Academy of Sleep Medicine (AASM) 2015 (recommended) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.]

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_o0h4
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events. The definition of hypopnea events is consistent with the following clinical guidelines: (1) AASM 2012 update (alternative) Berry RB et al. 2012 (PubMed ID:23066376), and (2) AASM 2015 (acceptable) [Berry RB et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.2. American Academy of Sleep Medicine, Darien, IL, 2015.].

Search for all AHI variables consistent with the same clinical guidelines within this dataset

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ahi_o0h4a
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography
Obstructive Apnea-Hypopnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and >= 4% oxygen desaturation or with arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events.

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
cai0p
Central Apnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
Central Apnea Index: (Central apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
oai0p
Obstructive Apnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography
Obstructive Apnea Index: (Obstructive apneas with no oxygen desaturation threshold used and with or without arousal) / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdi0p
Apnea-Hypopnea Index: Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and with no oxygen desaturation used and with or without arousal / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: Apneas with no oxygen desaturation threshold used and with or without arousal+ hypopneas with > 30% flow reduction and with no oxygen desaturation used and with or without arousal / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdi3p
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdi3pa
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation or with arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation or with arousal / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: Apneas with >=3% oxygen desaturation or with arousal+ hypopneas with > 30% flow reduction and >=3% oxygen desaturation or with arousal / hour of sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdi4p
Apnea-Hypopnea Index: Apneas with >=4% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=4% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography
Apnea-Hypopnea Index: Apneas with >=4% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and >=4% oxygen desaturation and with or without arousal / hour of sleep from type II polysomnography

Ratio of the count of all apneas (central and obstructive) and hypopneas associated with at least a >=4% oxygen desaturation to the total sleep time

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdinr3p
Apnea-Hypopnea Index (NREM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of NREM sleep from type II polysomnography
Apnea-Hypopnea Index (NREM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of NREM sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
rdirem3p
Apnea-Hypopnea Index (REM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of REM sleep from type II polysomnography
Apnea-Hypopnea Index (REM): Apneas with >= 3% oxygen desaturation and with or without arousal+ hypopneas with > 30% flow reduction and with >= 3% oxygen desaturation and with or without arousal / hour of REM sleep from type II polysomnography

Calculated - Summary metric of sleep disordered breathing events

Sleep Monitoring/Polysomnography/Apnea-Hypopnea Indices
ai_all
Arousal Index: Arousals per hour of sleep from type II polysomnography
Arousal Index: Arousals per hour of sleep from type II polysomnography

Total number of arousals per hour of sleep. Ratio of count of arousals to total sleep time in hours.

Sleep Monitoring/Polysomnography/Arousals
avgsat
Average oxygen saturation during total sleep duration from type II polysomnography
Average oxygen saturation during total sleep duration from type II polysomnography Sleep Monitoring/Polysomnography/Oxygen Saturation
minsat
Minimum oxygen saturation during total sleep duration from type II polysomnography
Minimum oxygen saturation during total sleep duration from type II polysomnography

Lowest oxygen saturation (SaO2)% during sleep

Sleep Monitoring/Polysomnography/Oxygen Saturation
overall_shhs2
Polysomnography (PSG) Quality Assessment (Sleep Heart Health Study Visit Two (SHHS2)): Overall signal quality
Polysomnography (PSG) Quality Assessment (Sleep Heart Health Study Visit Two (SHHS2)): Overall signal quality

Overall study grade as assigned by scorer. These codes reflected the total duration of useable (artifact free, scorable) signals during sleep time across channels, weighing those signals most critical for accurate scoring of respiratory events and staging during sleep time. The Quality Assessment Form for SHHS2 was modified so that the overall quality grade and the signal quality codes were based on signals during sleep time. Since events were only scored during sleep time this provided a more accurate assessment of signal quality during the actual time or scoring. This change would only have affected the quality grade of a small number of studies in SHHS1 where there was a significant amount of time awake with very good signals combined with very poor signals that occurred during sleep. The overall and signal quality grades are comparable between SHHS1 and SHHS2.

Sleep Monitoring/Polysomnography/Signal Quality/SHHS2
nsupinep
Percentage of total sleep duration in non-supine position from type II polysomnography
Percentage of total sleep duration in non-supine position from type II polysomnography

Percent of sleep time in non-supine body position

Sleep Monitoring/Polysomnography/Sleep Architecture
slpeffp
Sleep Efficiency: the ratio of sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from type II polysomnography
Sleep Efficiency: the ratio of sleep duration (i.e., total sleep time) to in-bed period (i.e., time in bed) from type II polysomnography

Sleep duration is the interval between sleep onset time and lights on/out-bed time while asleep (i.e. total sleep time, TST), while in-bed period is the interval between lights off/in-bed time and lights on/out-bed time (i.e. time in bed, TIB).Percentage of time in bed that was spent sleeping, or the ratio of total sleep time to total time in bed, expressed as a percentage.

Sleep Monitoring/Polysomnography/Sleep Architecture
slpprdp
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from type II polysomnography
Total Sleep Duration: the interval between sleep onset and sleep offset while the participant is asleep from type II polysomnography

Conventionally this variable would be called total sleep time (TST)(i.e. total time spent in stage 1 or greater).

Sleep Monitoring/Polysomnography/Sleep Architecture
supinep
Percentage of total sleep duration in supine position from type II polysomnography
Percentage of total sleep duration in supine position from type II polysomnography Sleep Monitoring/Polysomnography/Sleep Architecture
timeremp
Percentage of total sleep duration in REM from type II polysomnography
Percentage of total sleep duration in REM from type II polysomnography

The ratio of time in rapid eye movement sleep (REM) to total sleep time, expressed as a percentage.

Sleep Monitoring/Polysomnography/Sleep Architecture
times34p
Percentage of total sleep duration in stage 3 and 4 from type II polysomnography
Percentage of total sleep duration in stage 3 and 4 from type II polysomnography Sleep Monitoring/Polysomnography/Sleep Architecture
timest1p
Percentage of total sleep duration in stage 1 from type II polysomnography
Percentage of total sleep duration in stage 1 from type II polysomnography Sleep Monitoring/Polysomnography/Sleep Architecture
timest2p
Percentage of total sleep duration in stage 2 from type II polysomnography
Percentage of total sleep duration in stage 2 from type II polysomnography Sleep Monitoring/Polysomnography/Sleep Architecture
waso
Wake after Sleep Onset: the total duration between sleep onset and sleep offset time while being awake from type II polysomnography
Wake after Sleep Onset: the total duration between sleep onset and sleep offset time while being awake from type II polysomnography

Total amount of time spent awake after going to sleep

Sleep Monitoring/Polysomnography/Sleep Architecture
ess_s1
Epworth Sleepiness Scale: Total score
Epworth Sleepiness Scale: Total score

Calculated - Total score based on an 8-item questionnaires ranking likelihood of dozing off Johns MW 1991 (PubMed ID: 1798888). Scale 0-3 for individual items; 0 to 24 for overall score.

Search for all ESS variables within this dataset

Sleep Questionnaires/Hypersomnia/Epworth Sleepiness Scale (ESS)/SHHS1
ess_s2
Epworth Sleepiness Scale: Total score
Epworth Sleepiness Scale: Total score

Calculated - Total score based on an 8-item questionnaires ranking likelihood of dozing off Johns MW 1991 (PubMed ID: 1798888). Scale 0-3 for individual items; 0 to 24 for overall score.

Search for all ESS variables within this dataset

Sleep Questionnaires/Hypersomnia/Epworth Sleepiness Scale (ESS)/SHHS2
sh317
Sleep Habits (Sleep Heart Health Study Visit Two (SHHS2)): Doctor of Medicine (MD) diagnosed sleep disorder
Sleep Habits (Sleep Heart Health Study Visit Two (SHHS2)): Doctor of Medicine (MD) diagnosed sleep disorder

17. Have you ever been told by a doctor that you have a sleep disorder (other than sleep apnea)?

Sleep Questionnaires/Sleep Disorder
saqli
The Short Sleep Apnea Quality of Life Index (SAQLI) Score
The Short Sleep Apnea Quality of Life Index (SAQLI) Score

The Short Sleep Apnea Quality of Life Index (Short SAQLI) score

Sleep Questionnaires/Sleep Disordered Breathing
fosq
Functional Outcomes of Sleep Questionnaire (FOSQ) Score
Functional Outcomes of Sleep Questionnaire (FOSQ) Score Sleep Questionnaires/Sleep Disturbance
pptid
New SHHS participant ID assigned by BioLINCC
New SHHS participant ID assigned by BioLINCC

This participant ID matches what is present in Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC). From BioLINCC, this column may be called 'npptid'.

Administrative
calldt
Interim Follow-up: Days from index date to call
Interim Follow-up: Days from index date to call Administrative/Interim
cmplbp
Interim Follow-up: Completed blood pressure (BP)
Interim Follow-up: Completed blood pressure (BP) Administrative/Interim
cmplcvd
Interim Follow-up: Completed cardiovascular disease (CVD) events form (parent study form)
Interim Follow-up: Completed cardiovascular disease (CVD) events form (parent study form) Administrative/Interim
cmplmeds
Interim Follow-up: Completed medication form
Interim Follow-up: Completed medication form Administrative/Interim
cmplshq
Interim Follow-up: Completed sleep health questionnaire form
Interim Follow-up: Completed sleep health questionnaire form Administrative/Interim
cmplwt
Interim Follow-up: Completed weight
Interim Follow-up: Completed weight Administrative/Interim
comments
Interim Follow-up: Any comments
Interim Follow-up: Any comments Administrative/Interim
completeddt_scr
Interim Follow-up: Days from index date to date when screener form was completed
Interim Follow-up: Days from index date to date when screener form was completed Administrative/Interim
completeddt_stat
Interim Follow-up: Days from index date to date when status form was completed
Interim Follow-up: Days from index date to date when status form was completed Administrative/Interim
contact
Interim Follow-up: Able to contact participant
Interim Follow-up: Able to contact participant Administrative/Interim
formdt
Interim Follow-up: Days from index date to date when form was filled out
Interim Follow-up: Days from index date to date when form was filled out Administrative/Interim
fup_all
Interim Follow-up: All followup forms present
Interim Follow-up: All followup forms present Administrative/Interim
fup_scr
Interim Follow-up: Contact Form present
Interim Follow-up: Contact Form present Administrative/Interim
fup_slpsym
Interim Follow-up: Sleep Habits Form present
Interim Follow-up: Sleep Habits Form present Administrative/Interim
fup_stat
Interim Follow-up: Status, Blood Pressure and Weight Form present
Interim Follow-up: Status, Blood Pressure and Weight Form present Administrative/Interim
fuweight
Interim Follow-up: Follow up (FU) status weight
Interim Follow-up: Follow up (FU) status weight

Units are not consistent across observations; use wtunits to determine proper unit.

Administrative/Interim
intrevdt
Interim Follow-up: Days from index date to Interview or Review date
Interim Follow-up: Days from index date to Interview or Review date Administrative/Interim
langadmin
Interim Follow-up: Language in which interview was administered
Interim Follow-up: Language in which interview was administered Administrative/Interim
nocontact
Interim Follow-up: Reason contact not made
Interim Follow-up: Reason contact not made Administrative/Interim
pptstatus
Interim Follow-up: Participant Status
Interim Follow-up: Participant Status Administrative/Interim
readin_scr
Interim Follow-up: Days from index date to when screener record was read in at Coordinating Center (CC)
Interim Follow-up: Days from index date to when screener record was read in at Coordinating Center (CC) Administrative/Interim
readin_slpsym
Interim Follow-up: Days from index date to when sleep symptoms record was read in at Coordinating Center (CC)
Interim Follow-up: Days from index date to when sleep symptoms record was read in at Coordinating Center (CC) Administrative/Interim
readin_stat
Interim Follow-up: Days from index date to when status record was read in at Coordinating Center (CC)
Interim Follow-up: Days from index date to when status record was read in at Coordinating Center (CC) Administrative/Interim
reasrefused
Interim Follow-up: Reason refused repeat study
Interim Follow-up: Reason refused repeat study Administrative/Interim
repeat
Interim Follow-up: Willing to repeat study
Interim Follow-up: Willing to repeat study Administrative/Interim
scrfollowup
Interim Follow-up: Follow-up number
Interim Follow-up: Follow-up number Administrative/Interim
spclangadmin
Interim Follow-up: Other language in which interview was administered
Interim Follow-up: Other language in which interview was administered Administrative/Interim
spcnocontact
Interim Follow-up: Other reason contact not made
Interim Follow-up: Other reason contact not made Administrative/Interim
spcreasrefused
Interim Follow-up: Other reason refused repeat study
Interim Follow-up: Other reason refused repeat study Administrative/Interim
statusother
Interim Follow-up: Participant Status - other (text)
Interim Follow-up: Participant Status - other (text) Administrative/Interim
visitdt
Interim Follow-up: Days from index date to follow-up visit
Interim Follow-up: Days from index date to follow-up visit Administrative/Interim
whoadmin
Interim Follow-up: Who administered this form
Interim Follow-up: Who administered this form Administrative/Interim